학술논문
A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in uveal melanoma: safety, efficacy, and T cell responses.
Document Type
Article
Author
Smith, Katherine E. R.; Kah-Whye Peng; Pulido, Jose S.; Weisbrod, Adam J.; Strand, Carrie A.; Allred, Jacob B.; Newsom, Alysha N.; Lianwen Zhang; Packiriswamy, Nandakumar; Kottke, Timothy; Tonne, Jason M.; Moore, Madelyn; Montane, Heather N.; Kottschade, Lisa A.; McWilliams, Robert R.; Dudek, Arkadiusz Z.; Yiyi Yan; Dimou, Anastasios; Markovic, Svetomir N.; Federspiel, Mark J.
Source
Frontiers in Immunology; 2023, p1-11, 11p
Subject
Language
ISSN
16643224
Abstract
Copyright of Frontiers in Immunology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)